• Je něco špatně v tomto záznamu ?

Variants in Mitochondrial ATP Synthase Cause Variable Neurologic Phenotypes

M. Zech, R. Kopajtich, K. Steinbrücker, C. Bris, N. Gueguen, RG. Feichtinger, MT. Achleitner, N. Duzkale, M. Périvier, J. Koch, H. Engelhardt, P. Freisinger, M. Wagner, T. Brunet, R. Berutti, D. Smirnov, T. Navaratnarajah, RJT. Rodenburg, LS....

. 2022 ; 91 (2) : 225-237. [pub] 20220120

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22011090

Grantová podpora
Else Kröner-Fresenius-Stiftung
01GM1906A Federal Ministry of Education and Research
Technische Universität München
R00 HL143036 NHLBI NIH HHS - United States
I4704-B Federal Ministry of Education and Research
01KU2016A Federal Ministry of Education and Research
Medizinische Universität Innsbruck
NV19-04-00233 Ministry of Education
01GM1920A Federal Ministry of Education and Research
Research Foundation
Charles University
I4695-B Federal Ministry of Education and Research
Helmholtz Zentrum München
UM1 HG008900 NHGRI NIH HHS - United States
U01 HG011755 NHGRI NIH HHS - United States
R01 HG009141 NHGRI NIH HHS - United States

OBJECTIVE: ATP synthase (ATPase) is responsible for the majority of ATP production. Nevertheless, disease phenotypes associated with mutations in ATPase subunits are extremely rare. We aimed at expanding the spectrum of ATPase-related diseases. METHODS: Whole-exome sequencing in cohorts with 2,962 patients diagnosed with mitochondrial disease and/or dystonia and international collaboration were used to identify deleterious variants in ATPase-encoding genes. Findings were complemented by transcriptional and proteomic profiling of patient fibroblasts. ATPase integrity and activity were assayed using cells and tissues from 5 patients. RESULTS: We present 10 total individuals with biallelic or de novo monoallelic variants in nuclear ATPase subunit genes. Three unrelated patients showed the same homozygous missense ATP5F1E mutation (including one published case). An intronic splice-disrupting alteration in compound heterozygosity with a nonsense variant in ATP5PO was found in one patient. Three patients had de novo heterozygous missense variants in ATP5F1A, whereas another 3 were heterozygous for ATP5MC3 de novo missense changes. Bioinformatics methods and populational data supported the variants' pathogenicity. Immunohistochemistry, proteomics, and/or immunoblotting revealed significantly reduced ATPase amounts in association to ATP5F1E and ATP5PO mutations. Diminished activity and/or defective assembly of ATPase was demonstrated by enzymatic assays and/or immunoblotting in patient samples bearing ATP5F1A-p.Arg207His, ATP5MC3-p.Gly79Val, and ATP5MC3-p.Asn106Lys. The associated clinical profiles were heterogeneous, ranging from hypotonia with spontaneous resolution (1/10) to epilepsy with early death (1/10) or variable persistent abnormalities, including movement disorders, developmental delay, intellectual disability, hyperlactatemia, and other neurologic and systemic features. Although potentially reflecting an ascertainment bias, dystonia was common (7/10). INTERPRETATION: Our results establish evidence for a previously unrecognized role of ATPase nuclear-gene defects in phenotypes characterized by neurodevelopmental and neurodegenerative features. ANN NEUROL 2022;91:225-237.

Broad Center for Mendelian Genomics Broad Institute of MIT and Harvard Cambridge MA

Children's Hospital Kreiskliniken Reutlingen Germany

Département de Biochimie et Génétique Centre Hospitalier Universitaire d'Angers Angers France

Department of General Pediatrics Neonatology and Pediatric Cardiology University Children's Hospital Medical Faculty Heinrich Heine University Düsseldorf Germany

Department of Genetics Washington University School of Medicine St Louis MO

Department of Medical Genetic Diskapi Yildirim Beyazit Training and Research Hospital Ankara Turkey

Department of Neurology Charles University 1st Faculty of Medicine and General University Hospital Prague Prague Czech Republic

Department of Neurology Medical University of Innsbruck Innsbruck Austria

Department of Neuropediatrics and Muscle Disorders University Medical Center Faculty of Medicine University of Freiburg Freiburg Germany

Department of Pediatric Neurology University Children's Hospital Zurich University of Zurich Zurich Switzerland

Department of Pediatrics Washington University School of Medicine St Louis MO

Departments of Child Health Neurology and Cellular and Molecular Medicine and Program in Genetics University of Arizona College of Medicine Phoenix Phoenix AZ

Harvard Medical School and Center for Genomic Medicine Massachusetts General Hospital Boston and Laboratory for Molecular Medicine Partners Healthcare Personalized Medicine Cambridge MA

Institute of Neurogenomics Helmholtz Zentrum München Munich Germany

Kinderkrankenhaus St Marien gGmbH Zentrum für Kinder und Jugendmedizin Landshut Germany

Lehrstuhl für Neurogenetik Technische Universität München Munich Germany

Munich Cluster for Systems Neurology Munich Germany

Pediatric Movement Disorders Program Division of Pediatric Neurology Barrow Neurological Institute Phoenix Children's Hospital Phoenix AZ

Pediatric Neurology Department CHU Clocheville Tours France

Program in Medical and Population Genetics Broad Institute Cambridge MA

Radboud Center for Mitochondrial Medicine Department of Pediatrics Amalia Children's Hospital Radboud UMC Nijmegen The Netherlands

Radboud Centre for Mitochondrial Medicine Department of Paediatrics Radboud Institute for Molecular Life Sciences Radboud University Nijmegen Medical Centre Nijmegen Nijmegen The Netherlands

Technical University of Munich School of Medicine Institute of Human Genetics Munich Germany

Unité Mixte de Recherche MITOVASC CNRS 6015 INSERM 1083 Université d'Angers Angers France

University Children's Hospital Paracelsus Medical University Salzburg Austria

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011090
003      
CZ-PrNML
005      
20220506125802.0
007      
ta
008      
220425s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ana.26293 $2 doi
035    __
$a (PubMed)34954817
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zech, Michael $u Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany $1 https://orcid.org/0000000181129153
245    10
$a Variants in Mitochondrial ATP Synthase Cause Variable Neurologic Phenotypes / $c M. Zech, R. Kopajtich, K. Steinbrücker, C. Bris, N. Gueguen, RG. Feichtinger, MT. Achleitner, N. Duzkale, M. Périvier, J. Koch, H. Engelhardt, P. Freisinger, M. Wagner, T. Brunet, R. Berutti, D. Smirnov, T. Navaratnarajah, RJT. Rodenburg, LS. Pais, C. Austin-Tse, M. O'Leary, S. Boesch, R. Jech, S. Bakhtiari, SC. Jin, F. Wilbert, MC. Kruer, SB. Wortmann, M. Eckenweiler, JA. Mayr, F. Distelmaier, R. Steinfeld, J. Winkelmann, H. Prokisch
520    9_
$a OBJECTIVE: ATP synthase (ATPase) is responsible for the majority of ATP production. Nevertheless, disease phenotypes associated with mutations in ATPase subunits are extremely rare. We aimed at expanding the spectrum of ATPase-related diseases. METHODS: Whole-exome sequencing in cohorts with 2,962 patients diagnosed with mitochondrial disease and/or dystonia and international collaboration were used to identify deleterious variants in ATPase-encoding genes. Findings were complemented by transcriptional and proteomic profiling of patient fibroblasts. ATPase integrity and activity were assayed using cells and tissues from 5 patients. RESULTS: We present 10 total individuals with biallelic or de novo monoallelic variants in nuclear ATPase subunit genes. Three unrelated patients showed the same homozygous missense ATP5F1E mutation (including one published case). An intronic splice-disrupting alteration in compound heterozygosity with a nonsense variant in ATP5PO was found in one patient. Three patients had de novo heterozygous missense variants in ATP5F1A, whereas another 3 were heterozygous for ATP5MC3 de novo missense changes. Bioinformatics methods and populational data supported the variants' pathogenicity. Immunohistochemistry, proteomics, and/or immunoblotting revealed significantly reduced ATPase amounts in association to ATP5F1E and ATP5PO mutations. Diminished activity and/or defective assembly of ATPase was demonstrated by enzymatic assays and/or immunoblotting in patient samples bearing ATP5F1A-p.Arg207His, ATP5MC3-p.Gly79Val, and ATP5MC3-p.Asn106Lys. The associated clinical profiles were heterogeneous, ranging from hypotonia with spontaneous resolution (1/10) to epilepsy with early death (1/10) or variable persistent abnormalities, including movement disorders, developmental delay, intellectual disability, hyperlactatemia, and other neurologic and systemic features. Although potentially reflecting an ascertainment bias, dystonia was common (7/10). INTERPRETATION: Our results establish evidence for a previously unrecognized role of ATPase nuclear-gene defects in phenotypes characterized by neurodevelopmental and neurodegenerative features. ANN NEUROL 2022;91:225-237.
650    _2
$a dystonie $x enzymologie $x genetika $7 D004421
650    _2
$a epilepsie $x genetika $7 D004827
650    _2
$a genetická variace $7 D014644
650    _2
$a lidé $7 D006801
650    _2
$a mitochondrie $x enzymologie $x genetika $7 D008928
650    _2
$a mitochondriální ADP/ATP-translokasy $x genetika $7 D000226
650    _2
$a mitochondriální nemoci $x enzymologie $x genetika $7 D028361
650    _2
$a mitochondriální protonové ATPasy $x genetika $7 D025261
650    _2
$a molekulární modely $7 D008958
650    _2
$a mutace $7 D009154
650    _2
$a missense mutace $7 D020125
650    _2
$a nemoci nervového systému $x enzymologie $x genetika $7 D009422
650    _2
$a neurodegenerativní nemoci $x enzymologie $x genetika $7 D019636
650    _2
$a neurovývojové poruchy $x enzymologie $x genetika $7 D065886
650    _2
$a rodokmen $7 D010375
650    _2
$a fenotyp $7 D010641
650    _2
$a proteomika $7 D040901
650    _2
$a sekvenování exomu $7 D000073359
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kopajtich, Robert $u Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany $1 https://orcid.org/0000000291193455
700    1_
$a Steinbrücker, Katja $u University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria
700    1_
$a Bris, Céline $u Unité Mixte de Recherche MITOVASC, CNRS 6015/INSERM 1083, Université d'Angers, Angers, France $u Département de Biochimie et Génétique, Centre Hospitalier Universitaire d'Angers, Angers, France
700    1_
$a Gueguen, Naig $u Unité Mixte de Recherche MITOVASC, CNRS 6015/INSERM 1083, Université d'Angers, Angers, France $u Département de Biochimie et Génétique, Centre Hospitalier Universitaire d'Angers, Angers, France
700    1_
$a Feichtinger, René G $u University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria $1 https://orcid.org/0000000242158258
700    1_
$a Achleitner, Melanie T $u University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria
700    1_
$a Duzkale, Neslihan $u Department of Medical Genetic, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey
700    1_
$a Périvier, Maximilien $u Pediatric Neurology Department, CHU Clocheville, Tours, France
700    1_
$a Koch, Johannes $u University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria
700    1_
$a Engelhardt, Harald $u Kinderkrankenhaus St. Marien gGmbH, Zentrum für Kinder- und Jugendmedizin, Landshut, Germany
700    1_
$a Freisinger, Peter $u Children's Hospital Kreiskliniken, Reutlingen, Germany
700    1_
$a Wagner, Matias $u Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany $1 https://orcid.org/0000000244548823
700    1_
$a Brunet, Theresa $u Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany $1 https://orcid.org/000000025183780X
700    1_
$a Berutti, Riccardo $u Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany
700    1_
$a Smirnov, Dmitrii $u Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany $1 https://orcid.org/000000025802844X
700    1_
$a Navaratnarajah, Tharsini $u Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany
700    1_
$a Rodenburg, Richard J T $u Radboud Centre for Mitochondrial Medicine, Department of Paediatrics Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen Medical Centre Nijmegen, Nijmegen, The Netherlands
700    1_
$a Pais, Lynn S $u Program in Medical and Population Genetics, Broad Institute, Cambridge, MA
700    1_
$a Austin-Tse, Christina $u Harvard Medical School & Center for Genomic Medicine, Massachusetts General Hospital, Boston & Laboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Cambridge, MA
700    1_
$a O'Leary, Melanie $u Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard, Cambridge, MA
700    1_
$a Boesch, Sylvia $u Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria
700    1_
$a Jech, Robert $u Department of Neurology, Charles University, 1st Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Bakhtiari, Somayeh $u Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ $u Departments of Child Health, Neurology, and Cellular & Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine-Phoenix, Phoenix, AZ
700    1_
$a Jin, Sheng Chih $u Department of Genetics, Washington University School of Medicine, St. Louis, MO $u Department of Pediatrics, Washington University School of Medicine, St Louis, MO
700    1_
$a Wilbert, Friederike $u Department of Neuropediatrics and Muscle Disorders, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
700    1_
$a Kruer, Michael C $u Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, AZ $u Departments of Child Health, Neurology, and Cellular & Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine-Phoenix, Phoenix, AZ
700    1_
$a Wortmann, Saskia B $u University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria $u Radboud Center for Mitochondrial Medicine, Department of Pediatrics, Amalia Children's Hospital, Radboud UMC, Nijmegen, The Netherlands
700    1_
$a Eckenweiler, Matthias $u Department of Neuropediatrics and Muscle Disorders, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
700    1_
$a Mayr, Johannes A $u University Children's Hospital, Paracelsus Medical University (PMU), Salzburg, Austria
700    1_
$a Distelmaier, Felix $u Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany
700    1_
$a Steinfeld, Robert $u Department of Pediatric Neurology, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland
700    1_
$a Winkelmann, Juliane $u Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany $u Lehrstuhl für Neurogenetik, Technische Universität München, Munich, Germany $u Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
700    1_
$a Prokisch, Holger $u Technical University of Munich, School of Medicine, Institute of Human Genetics, Munich, Germany $u Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany $1 https://orcid.org/0000000323796286
773    0_
$w MED00000428 $t Annals of neurology $x 1531-8249 $g Roč. 91, č. 2 (2022), s. 225-237
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34954817 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506125754 $b ABA008
999    __
$a ok $b bmc $g 1788935 $s 1162288
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 91 $c 2 $d 225-237 $e 20220120 $i 1531-8249 $m Annals of neurology $n Ann Neurol $x MED00000428
GRA    __
$p Else Kröner-Fresenius-Stiftung
GRA    __
$a 01GM1906A $p Federal Ministry of Education and Research
GRA    __
$p Technische Universität München
GRA    __
$a R00 HL143036 $p NHLBI NIH HHS $2 United States
GRA    __
$a I4704-B $p Federal Ministry of Education and Research
GRA    __
$a 01KU2016A $p Federal Ministry of Education and Research
GRA    __
$p Medizinische Universität Innsbruck
GRA    __
$a NV19-04-00233 $p Ministry of Education
GRA    __
$a 01GM1920A $p Federal Ministry of Education and Research
GRA    __
$p Research Foundation
GRA    __
$p Charles University
GRA    __
$a I4695-B $p Federal Ministry of Education and Research
GRA    __
$p Helmholtz Zentrum München
GRA    __
$a UM1 HG008900 $p NHGRI NIH HHS $2 United States
GRA    __
$a U01 HG011755 $p NHGRI NIH HHS $2 United States
GRA    __
$a R01 HG009141 $p NHGRI NIH HHS $2 United States
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...